Navigation Links
Team to study control of malaria-related parasite growth with $2.1-million NIH grant
Date:1/23/2014

Animal cells similar to those of humans contain a "control room," called the centrosome, which regulates cell replication. Disrupt this core hub and you kill cell division.

That is the simple idea behind a new five-year, $2.1-million National Institutes for Health grant recently awarded to the USF College of Public Health's Department of Global Health and the Florida Center for Drug Development and Innovation.

The National Institute of Allergy and Infectious Diseases-funded study may help identify new factors required for the growth of malaria-related parasites and lead to new therapies to combat malaria, a mosquito-borne tropical disease that exacts a huge toll on human health in developing countries.

The project began with a key discovery by Michael White, PhD, professor of global health at USF Health, and Elena Suvorova, PhD, a research assistant professor at the USF Center for Drug Development and Innovation (CDDI).

They showed that in malaria-related parasites known as Toxoplasma gondii the centrosome is more complex and very different from their human hosts. The parasite hub houses novel factors, including unusual protein kinases, or enzymes, that offer new targets for drug development.

Principal investigator White and co-principal investigator Suvorova will collaborate with newly hired CDDI medicinal chemist Jim Leahy, PhD, an expert in developing drugs against kinases in cancer, and University of Georgia cell biologist Boris Striepen, PhD, to study centrosome control of Toxoplasma growth.


'/>"/>

Contact: Anne DeLotto Baier
abaier@health.usf.edu
813-974-3303
University of South Florida (USF Health)
Source:Eurekalert  

Page: 1

Related medicine news :

1. Practice makes perfect if you have a partners touch, according to new study
2. Study shows 1 in 5 women with ovarian cancer has inherited predisposition
3. Study could lead to liquid biopsy tests for bladder cancer
4. New study examines patterns of cancer screening in Appalachian women
5. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
6. Study: Possible new druggable target in Ewings Sarcoma
7. Miriam Hospital study links intimate partner violence and risk of HIV
8. Study reveals how ecstasy acts on the brain and hints at therapeutic uses
9. Study finds troubling relationship between drinking and PTSD symptoms in college students
10. China Laser Equipment Industry Production Capacity to Be 2.77 Times More by 2017 in a New Study at MarketReportsChina.com
11. Study questions anti-cancer mechanisms of drug tested in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Team to study control of malaria-related parasite growth with $2.1-million NIH grant
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: